Abstract
Purpose
Catheter ablation of atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) is still challenging, and it is unclear whether the difficulty is caused by the hypertrophy of left atrial (LA) myocardial wall thickness. The objective of the study was to compare the LA wall thickness and AF ablation outcomes between patients with HCM and those without structural heart disease.
Methods
The present study enrolled 17 consecutive HCM patients (63 ± 12 years) with drug-refractory AF and 34 control patients without any detectable heart disease, whose age, gender, type of AF, and LA dimension were matched to the HCM patients. The myocardial wall thickness of 11 distinct LA locations, measured using 64-slice computed tomography images, and AF ablation outcomes were compared between the two groups.
Results
The LA wall thickness did not differ at 9 of the 11 locations and was significantly thinner in the HCM patients than in the control patients at the mid-posterior wall (1.44 ± 0.17 vs. 1.58 ± 0.22, p = 0.04) and infero-posterior wall (1.62 ± 0.16 vs. 1.74 ± 0.18, p = 0.03). Although antiarrhythmic drugs were used more frequently in the HCM patients (p = 0.008), the rate of maintaining sinus rhythm during the follow-up did not differ between the HCM and control patients (53 vs. 56 % after the initial ablation [log-rank p = 0.78] and 82 and 88 % after the repeat procedure [log-rank p = 0.35]).
Conclusions
The LA wall in the HCM patients with AF was not thicker than that of the matched patients without structural heart disease. Catheter ablation of AF showed favorable outcomes in both patient groups.
Similar content being viewed by others
References
Maron, B. J., Olivotto, I., Bellone, P., Conte, M. R., Cecchi, F., Flygenring, B. P., et al. (2002). Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol, 39(2), 301–307.
Maron, B. J., Casey, S. A., Poliac, L. C., Gohman, T. E., Almquist, A. K., & Aeppli, D. M. (1999). Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA, 281(7), 650–655.
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001). Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation, 104(21), 2517–2524.
Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., et al. (2005). Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol, 45(8), 1251–1258.
Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol, 3(1), 32–38.
Di Donna, P., Olivotto, I., Delcre, S. D., Caponi, D., Scaglione, M., Nault, I., et al. (2010). Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. Europace, 12(3), 347–355.
Bunch, T. J., Munger, T. M., Friedman, P. A., Asirvatham, S. J., Brady, P. A., Cha, Y. M., et al. (2008). Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol, 19(10), 1009–1014.
Gaita, F., Di Donna, P., Olivotto, I., Scaglione, M., Ferrero, I., Montefusco, A., et al. (2007). Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol, 99(11), 1575–1581.
Kilicaslan, F., Verma, A., Saad, E., Themistoclakis, S., Bonso, A., Raviele, A., et al. (2006). Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm, 3(3), 275–280.
Losi, M. A., Betocchi, S., Aversa, M., Lombardi, R., Miranda, M., D'Alessandro, G., et al. (2004). Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol, 94(7), 895–900.
Chen, M. S., McCarthy, P. M., Lever, H. M., Smedira, N. G., & Lytle, B. L. (2004). Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. Am J Cardiol, 93(3), 373–375.
Klues, H. G., Schiffers, A., & Maron, B. J. (1995). Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol, 26(7), 1699–1708.
McKenna, W. J., Spirito, P., Desnos, M., Dubourg, O., & Komajda, M. (1997). Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart, 77(2), 130–132.
Tadros, T. M., Massaro, J. M., Rosito, G. A., Hoffmann, U., Vasan, R. S., Larson, M. G., et al. (2010). Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity (Silver Spring), 18(5), 1039–1045.
Abbara, S., Desai, J. C., Cury, R. C., Butler, J., Nieman, K., & Reddy, V. (2006). Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. Eur J Radiol, 57(3), 417–422.
Sanders, P., Hocini, M., Jais, P., Sacher, F., Hsu, L. F., Takahashi, Y., et al. (2007). Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome. Eur Heart J, 28(15), 1862–1871.
Jais, P., Hocini, M., Hsu, L. F., Sanders, P., Scavee, C., Weerasooriya, R., et al. (2004). Technique and results of linear ablation at the mitral isthmus. Circulation, 110(19), 2996–3002.
Ouyang, F., Tilz, R., Chun, J., Schmidt, B., Wissner, E., Zerm, T., et al. (2010). Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation, 122(23), 2368–2377.
Beinart, R., Abbara, S., Blum, A., Ferencik, M., Heist, K., Ruskin, J., et al. (2011). Left atrial wall thickness variability measured by CT scans in patients undergoing pulmonary vein isolation. J Cardiovasc Electrophysiol, 22(11), 1232–1236.
Platonov, P. G., Ivanov, V., Ho, S. Y., & Mitrofanova, L. (2008). Left atrial posterior wall thickness in patients with and without atrial fibrillation: data from 298 consecutive autopsies. J Cardiovasc Electrophysiol, 19(7), 689–692.
Suenari, K., Nakano, Y., Hirai, Y., Ogi, H., Oda, N., Makita, Y., et al. (2012). Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart Vessel, 28(3), 360–368.
Tani, T., Tanabe, K., Ono, M., Yamaguchi, K., Okada, M., Sumida, T., et al. (2004). Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr, 17(6), 644–648.
Lemola, K., Sneider, M., Desjardins, B., Case, I., Han, J., Good, E., et al. (2004). Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation. Circulation, 110(24), 3655–3660.
Acknowledgments
This work was supported by national grant, named MEXT KAKENHI Grant Number 22790735.
Conflict of interest
All the authors have none to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayashi, H., Hayashi, M., Miyauchi, Y. et al. Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Interv Card Electrophysiol 40, 153–160 (2014). https://doi.org/10.1007/s10840-014-9894-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-014-9894-y